⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26011205 | 1.00 | — | — | |
| SCHEMBL1086946 | 1.00 | — | — | |
| SCHEMBL26011209 | 1.00 | — | — | |
| SCHEMBL30917693 | 1.00 | — | — | |
| SCHEMBL84792 | 1.00 | — | — | |
| Bromide SCHEMBL7595850 | 0.98 | POLB (0.48) | — | |
| Iodide SCHEMBL28525835 | 0.98 | POLB (0.48) | — | |
| SCHEMBL7328192 | 0.95 | POLB (0.47) | — | |
| Lithium Ion SCHEMBL7328185 | 0.93 | POLB (0.45) | — | |
| SCHEMBL25262256 | 0.93 | CYP1A2 (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1789 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107083-A2 | SHELF-STABLE LOXSH CATALYST SOLUTION COMPOSITIONS COMPRISING SOLUBLE HIGH HYDRIDE CONCENTRATIONS AND THE PROCESSES FOR PREPARING THEM | ALBEMARLE CORPORATION (US) | 2026-05-21 | — | — | WO | claimed |
| US-20250179233-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2025-06-05 | — | — | US | claimed |
| US-20250136891-A1 | PERFUME CONCRETE AND ABSOLUTE WHICH ARE OBTAINED BY ORGANIC (POLY)OL SOLVENT EXTRACTION FROM SOLID NATURAL SUBSTANCES | L'OREAL (FR) | 2025-05-01 | — | — | US | claimed |
| EP-4511463-A2 | PERFUME CONCRETE AND ABSOLUTE WHICH ARE OBTAINED BY ORGANIC (POLY)OL SOLVENT EXTRACTION FROM SOLID NATURAL SUBSTANCES | L'OREAL (FR) | 2025-02-26 | — | — | EP | claimed |
| EP-4511372-A1 | PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB | Mirati Therapeutics, Inc. (US) | 2025-02-26 | — | — | EP | claimed |
| US-20250059163-A1 | FUSED RING COMPOUNDS | GENENTECH INC (US) | 2025-02-20 | — | — | US | claimed |
| EP-4486808-A2 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2025-01-08 | — | — | EP | claimed |
| CN-119137172-A | Process and catalyst for hydrogen-mediated anionic copolymerization of conjugated dienes and liquid copolymers thereof | 雅宝公司 | 2024-12-13 | — | — | CN | claimed |
| US-20240400558-A1 | PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB | MIRATI THERAPEUTICS, INC | 2024-12-05 | — | — | US | claimed |
| US-20240262866-A1 | METHOD FOR PREPARING ANIDULAFUNGIN DERIVATIVE | JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) | 2024-08-08 | — | — | US | claimed |
| EP-1226126-A1 | PYRIMIDINE DERIVATIVES | AstraZeneca AB (SE) | 2002-07-31 | — | — | EP | claimed |
| CN-1360582-A | Quinazoline derivs. | ASTRAZENECA UK LTD (GB) | 2002-07-24 | — | — | CN | claimed |
| WO-2002002534-A1 | QUINAZOLINES WITH THERAPEUTIC USE | ASTRAZENECA AB (SE) | 2002-01-10 | — | — | WO | claimed |
| WO-2002000644-A1 | GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES | ASTRAZENECA AB (SE) | 2002-01-03 | — | — | WO | claimed |
| US-6231849-B1 | HUNTING | Schiller, George A. | 2001-05-15 | — | — | US | claimed |
| WO-2001027089-A1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-04-19 | — | — | WO | claimed |
| EP-0703911-B1 | SECONDARY AMINES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | PFIZER (US) | 1997-07-02 | — | — | EP | claimed |
| US-5516915-A | Bis-(1H-indol-3-yl)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | GOEDECKE AKTIENGESELLSCHAFT (DE) | 1996-05-14 | — | — | US | claimed |
| EP-0370236-B1 | INDOLOCARBAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1991-12-27 | — | — | EP | claimed |
| US-4321387-A | Process for the preparation of optically active nicotine analogs | PHILIP MORRIS, INCORPORATED (US) | 1982-03-23 | — | — | US | claimed |